1-(4-benzyl-1,4-oxazepan-2-yl)methanamine, 95.0%, 250mg

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one, 98%, 100mg

5-(Trifluoromethyl)-1-indanone, 95.0%, 5g

2,5-DIAZASPIRO[3.4]OCTAN-6-ONE HCL, 95.0%, 250mg

Ethyl 2-amino-6-phenyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate, 97%, 100mg

(2-Oxo-2,3-dihydrobenzo[d]oxazol-5-yl)boronic acid, 97%, 100mg

Gestell f. Probenr. und Dosen, 5x10 Plätze, f. Röhrchen-Ø 32 mm, 1 Stück

N,N-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 1g

1-[1-(4-fluorobenzyl)-1H-imidazol-2-yl]methanamine hydrochloride (1:1), 1g

(2S,5S)-1-{2-[(2S,5S)-2,5-Diethylphospholan-1-yl]phenyl}-2,5-diethylphospholane1-oxide, 97%, 1g

2-Amino-2-(3,4-difluorophenyl)propan-1-ol, 98%, 500mg

3,3,3-Trifluoropropionic acid, 98.0%, 5g

N-Benzylprop-2-yn-1-amine, 97%, 100mg